Patents by Inventor Gabriele Hahn

Gabriele Hahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7892822
    Abstract: Recombinant vectors containing infectious viral genomic sequences as well as sequences of a cloning vehicle, a cell comprising the vector, a method for producing the vectors, a method of mutagenizing an infectious viral genomic sequence in the vector, and a vector obtained by the method.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: February 22, 2011
    Inventors: Ulrich H. Koszinowski, Martin Messerle, Wolfram Brune, Gabriele Hahn
  • Publication number: 20100267121
    Abstract: A recombinant vector containing infectious genome of human cytomegalovirus (HCMV) and being useful for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion is characterized in that it is obtainable by inserting DNA from a clinical isolate of HCMV virus into a bacterial cloning vehicle. Such vector can be used e.g., for production of reconstituted HCMV virus retaining the phenotypic characteristics of a parental clinical isolate and for studying genes and functions of genes of HCMV virus. A further aspect are mutant viruses and inter alia their use for studying aspects of infectivity of HCMV virus.
    Type: Application
    Filed: December 11, 2009
    Publication date: October 21, 2010
    Applicants: Vical Incorporated, Wistar Institute
    Inventor: Gabriele Hahn
  • Patent number: 7700350
    Abstract: A recombinant vector containing infectious genome of human cytomegalovirus (HCMV) and being useful for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion is characterized in that it is obtainable by inserting DNA from a clinical isolate of HCMV virus into a bacterial cloning vehicle. Such vector can be used e.g., for production of reconstituted HCMV virus retaining the phenotypic characteristics of a parental clinical isolate and for studying genes and functions of genes of HCMV virus. A further aspect are mutant viruses and inter alia their use for studying aspects of infectivity of HCMV virus.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: April 20, 2010
    Assignee: Vical Incorporated
    Inventor: Gabriele Hahn
  • Publication number: 20060019369
    Abstract: A recombinant vector containing infectious genome of human cytomegalovirus (HCMV) and being useful for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion is characterized in that it is obtainable by inserting DNA from a clinical isolate of HCMV virus into a bacterial cloning vehicle. Such vector can be used e.g., for production of reconstituted HCMV virus retaining the phenotypic characteristics of a parental clinical isolate and for studying genes and functions of genes of HCMV virus. A further aspect are mutant viruses and inter alia their use for studying aspects of infectivity of HCMV virus.
    Type: Application
    Filed: July 13, 2005
    Publication date: January 26, 2006
    Inventor: Gabriele Hahn
  • Publication number: 20040110188
    Abstract: The patent application PCT/EP02/01867 (WO 02/066629) “Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates” describes the cloning of a leukotropic and endothelial cell tropic clinical isolate of human cytomegalovirus (HCMV) as a bacterial artificial chromosome (BAC) in E. coli. The cloned wild-type genome of HCMV was designated FIX-BAC (Fusion-Inducing-Factor-X)-BAC (Hahn, Khan et al., 2002). The patent application PCT/EP02/01867 (WO 02/066629) also describes the construction of virus mutants using FIX-BAC technology and subsequent phenotypical testing of virus mutants for loss of wild-type features such as leukocyte and endothelial cell tropism. The genetic determinants of endothelial cell and leukocyte tropism were assigned to the UL132-UL128 genetic locus of HCMV.
    Type: Application
    Filed: July 15, 2003
    Publication date: June 10, 2004
    Inventor: Gabriele Hahn
  • Publication number: 20040087001
    Abstract: A recombinant vector containing infectious genome of human cytomegalovirus (HCMV) and being useful for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion is characterized in that it is obtainable by inserting DNA from a clinical isolate of HCMV virus into a bacterial cloning vehicle. Such vector can be used e.g. for production of reconstituted HCMV virus retaining the phenotypic characteristics of a parental clinical isolate and for studying genes and functions of genes of HCMV virus. A further aspect are mutant viruses and inter alia their use for studying aspects of infectivity of HCMV virus.
    Type: Application
    Filed: November 13, 2002
    Publication date: May 6, 2004
    Inventor: Gabriele Hahn